Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Zhejiang Shouxian Valley Pharmaceutical Joint-Stock Co., Ltd. Announcement on the Addition of Certified Public Accountants
Security Code: 603896 | Stock Short Name: Shouxiangu | Announcement No.: 2026-004
Bond Code: 113660 | Bond Short Name: Shou 22 Convertible Bond
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
Announcement on Adding a Signed Registered Public Accountant
The board of directors of the Company and all its directors hereby warrant that this announcement contains no false records, misleading statements, or material omissions, and will assume individual and joint liability for the truthfulness, accuracy, and completeness of the contents of this announcement.
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (hereinafter referred to as the “Company”) convened the 28th meeting of the fourth session of the board of directors on April 17, 2025. The meeting deliberated and approved the proposal on “Reappointing the Company’s Audit Firm for FY2025,” and agreed to continue appointing the accounting firm of BDO China Shuoyang Certified Public Accountants (Special General Partnership) (hereinafter referred to as “BDO Shuoyang”) as the Company’s audit firm for FY2025. BDO Shuoyang will be responsible for the audit of the Company’s financial statements, the audit of internal controls, and other related audit work. For details, please refer to the Company’s announcement titled “Announcement on Reappointing the Accounting Firm” published on April 18, 2025 on the website of the Shanghai Stock Exchange (www.see.com.cn) (Announcement No.: 2025-020).
Recently, the Company received from BDO Shuoyang a letter titled “Letter on the Addition of a Signed Registered Public Accountant for the Audit Firm of Zhejiang Shouxiangu Pharmaceutical Co., Ltd.” The relevant matters are hereby announced as follows:
I. Circumstances Concerning the Addition of the Signed Registered Public Accountant in This Instance
As the audit firm for the Company’s FY2025 financial statement audit, BDO Shuoyang originally assigned Zhu Zuowu as the project partner and signed registered public accountant, and Lü Qi as the signed registered public accountant, to provide audit services to the Company. Now, due to internal work arrangements of BDO Shuoyang, it has added Liu Qiaowei as the signed registered public accountant. After this adjustment, Zhu Zuowu will continue to serve as the project partner and signed registered public accountant, while Liu Qiaowei and Lü Qi will serve as the signed registered public accountants, to further complete the Company’s FY2025 audit-related work.
II. Relevant Information on the Signed Registered Public Accountant Added in This Instance
Liu Qiaowei has been engaged in the audit work for listed companies since 2014. In 2019, she/he became a practicing certified public accountant. Liu Qiaowei has been practicing at BDO Shuoyang since 2014 and has professional competence to perform the duties. In the past three years, there were 0 listed company audit reports signed.
Liu Qiaowei has no circumstances that violate the requirements for independence set forth in the “Code of Professional Ethics for Chinese Certified Public Accountants,” and has not been subject to any criminal punishment, administrative penalty, administrative regulatory measures, or self-disciplinary actions in the past three years. This complies with the provisions on regular rotation, and there is no record of poor integrity.
This adjustment will not have any adverse impact on the Company’s FY2025 audit work.
III. Documents for Reference
BDO Shuoyang’s “Letter on the Addition of a Signed Registered Public Accountant for the Audit Firm of Zhejiang Shouxiangu Pharmaceutical Co., Ltd.”
This announcement is hereby issued.
Board of Directors of Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
April 1, 2026
Endless information and precise interpretation—available in the Sina Finance APP